According to WiseGuy Reports, the Erucylamide Market was valued at USD 1,951.2 million in 2024 and reached USD 2,056.5 million in 2025. The market is projected to grow to USD 3,500.0 million by 2035, registering a CAGR of 5.4% during the forecast period. Market growth is driven by rising demand in pharmaceuticals, expanding agricultural applications, increasing investment in research and...